Tislelizumab Uses, Dosage, Side Effects and more
Tislelizumab is under investigation in clinical trial NCT02660034 (The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Subjects With Advanced Solid Tumors).
| Trade Name | Tislelizumab |
| Generic | Tislelizumab |
| Tislelizumab Other Names | Tislelizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
